Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-174411

Options or other derivatives

  • General Counsel acquired 7,224 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Murdock Hunter R. General Counsel 2026-04-21 Grant or award · Performance Stock Units +7,224 7,224 D: show line 1 in the form
Loading xslF345X06/ownership.xml…